Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research Article

Changes of Thymidine Kinase (TK) During Adjuvant and Palliative Chemotherapy

O. TOPOLCAN, L. HOLUBEC, J. FINEK, P. STIEBER, S. HOLDENRIEDER, R. LAMERZ, L. HOLUBEC SEN, S. SVOBODOVA, V. VISOKAI and L. LIPSKA
Anticancer Research May 2005, 25 (3A) 1831-1833;
O. TOPOLCAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: holubec@fnplzen.cz
L. HOLUBEC JR.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. FINEK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. STIEBER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. HOLDENRIEDER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. LAMERZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. HOLUBEC SEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. SVOBODOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. VISOKAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. LIPSKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Thymidine kinase is involved in nucleic acid synthesis and is, therefore, considered to be an important proliferation tumor marker. For this reason, we monitored this marker in the course of colorectal cancer chemotherapy. Materials and Methods: We examined thymidine kinase (TK) levels in 30 patients with colorectal cancer who underwent adjuvant or palliative chemotherapy (CHT schemes). The condition for being included in the study was a minimum of 3 cycles of chemotherapy. TK was always assessed with radio-receptor analysis, before and after every chemotherapy cycle, together with other tumor markers. Results: From the monitored tumor markers, only TK changed typically in the course of chemotherapy. In adjuvant chemotherapy, it was mostly low at the beginning of the cycle and its values usually increased considerably at the end. On the other hand, in palliative chemotherapy the dynamics of TK varied mainly depending on the effect of the therapy. Other tumor markers showed non-standard behavior and minimal correlation with TK changes. Conclusion: Thymidine kinase seems to be a suitable parameter for monitoring the effect of adjuvant and palliative chemotherapy in colorectal cancer.

  • Chemotherapy control
  • thymidinekinase
  • colorectal cancer
  • Received August 2, 2004.
  • Accepted February 8, 2005.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 25 (3A)
Anticancer Research
Vol. 25, Issue 3A
1 May 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Changes of Thymidine Kinase (TK) During Adjuvant and Palliative Chemotherapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Changes of Thymidine Kinase (TK) During Adjuvant and Palliative Chemotherapy
O. TOPOLCAN, L. HOLUBEC, J. FINEK, P. STIEBER, S. HOLDENRIEDER, R. LAMERZ, L. HOLUBEC SEN, S. SVOBODOVA, V. VISOKAI, L. LIPSKA
Anticancer Research May 2005, 25 (3A) 1831-1833;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Changes of Thymidine Kinase (TK) During Adjuvant and Palliative Chemotherapy
O. TOPOLCAN, L. HOLUBEC, J. FINEK, P. STIEBER, S. HOLDENRIEDER, R. LAMERZ, L. HOLUBEC SEN, S. SVOBODOVA, V. VISOKAI, L. LIPSKA
Anticancer Research May 2005, 25 (3A) 1831-1833;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Clinical Applicability of the Proliferation Marker Thymidine Kinase 1 in Head and Neck Cancer Patients
  • Google Scholar

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire